Literature DB >> 34402075

Assessment of health and welfare in a small sample of dogs owned by people who are homeless.

Louise Scanlon1, Pru Hobson-West1,2, Kate Cobb1, Anne McBride3, Jenny Stavisky1.   

Abstract

BACKGROUND: Pet ownership is common among homeless people, with dogs the most frequently reported pets. However, homeless people receive considerable criticism for keeping pets due to public perception of poor care provision.
MATERIALS AND METHODS: A convenience, cross-sectional sample of 19 homeless people, owning a total of 21 dogs were recruited, and their dogs' health and wellbeing assessed using the PDSA Petwise MOT (P-MOT).
RESULTS: The dogs compared favourably with conventionally owned pets in most areas, including exercise and companionship. Problems included being overweight/obese (although at lower prevalence than the general population). Some owners had difficulty in accessing veterinary care. Behavioural concerns were reported for 61.9% of the dogs, most commonly separation-related distress. DISCUSSION: Being unable to safely leave their pets may impair owners' access to services. Provision of accessible veterinary care, behavioural support and pet-friendly services could improve the health of homeless owners and their pets.
© 2021 The Authors. Veterinary Record published by John Wiley & Sons Ltd on behalf of British Veterinary Association.

Entities:  

Mesh:

Year:  2021        PMID: 34402075     DOI: 10.1002/vetr.776

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.560


  1 in total

1.  Serosurvey of anti-Toxocara canis antibodies in people experiencing homelessness and shelter workers from São Paulo, Brazil.

Authors:  Vamilton Alvares Santarém; Anahi Chechia do Couto; Susana Zevallos Lescano; William Henry Roldán; Ruana Renostro Delai; Rogério Giuffrida; Louise Bach Kmetiuk; Alexander Welker Biondo; Sriveny Dangoudoubiyam; Andrea Pires Dos Santos
Journal:  Parasit Vectors       Date:  2022-10-17       Impact factor: 4.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.